Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Project to Expand Systems Biology Research

By LabMedica International staff writers
Posted on 03 Aug 2010
Advancing the study of systems biology is the object of a major Swiss interdisciplinary research consortium.

SystemsX.ch (Zurich, Switzerland) is currently the largest research initiative in Switzerland with the mandate to promote systems biology. More...
It is a consortium with nine universities and three research institutions as partners. The program is funded by the Swiss federal budget with matching funds paid by those partners receiving grants. The SystemsX.ch project currently supports about 750 researchers from 250 research groups in 62 approved projects. About half of the 250 research group leaders are biologists by training. The other half comprises chemists, physicists, engineers, computational scientists, medical scientists, mathematicians, and economists.

Two of the SystemsX.ch partners, AB SCIEX (Foster City, CA, USA) and the ETH Zurich Institute of Molecular Systems Biology (Zurich, Switzerland), recently announced a joint project to accelerate analysis and improve results for metabolomics.

Investigators at ETH will be using the AB SCIEX QTRAP 5500 System to develop a new method to reduce the time required for quantitative analysis of metabolites from approximately one hour to less than three minutes, while delivering comprehensive results. The QTRAP 5500 System is a mass spectrometry system that integrates triple quadrupole and linear accelerator trap technologies onto a single platform for faster and more accurate analysis of complex samples.

Dr. Uwe Sauerp, professor of systems biology at ETH Zurich Institute of Molecular Systems Biology, said, "Our partnering with AB SCIEX on new method development for metabolomics will drive the field of systems biology forward by addressing the need for more quantitative, comprehensive data that can be quickly obtained. The new method we are currently developing could be used for any analysis of any biological system. The AB SCIEX technology gives us unique capabilities to get the best possible data in the shortest period of time that we can apply to make a major difference in systems biology and biomedical research.”

Mr. Dave Hicks, a vice president at AB SCIEX, said, "Our project with ETH will help researchers make significant progress in metabolomics research more rapidly than was previously possible. This demonstrates how AB SCIEX mass spectrometry technology continues to advance life science by enabling new workflows that combine targeted and nontargeted analysis of the metabolome for a new approach to understand the role and impact of metabolites in biology.”

Related Links:
SystemsX.ch
AB SCIEX
ETH Zurich Institute of Molecular Systems Biology


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.